Physician profile
Komal Patel
NPI 1912634551
$1,466.98
in general payments reported to CMS, 2019-2025
12 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $123 · 2024: $884 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,466.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $657.85 | 2023-2025 | Reveal Linq, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Atricure, INC. | $216.97 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $132.90 | 2024 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $122.80 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.68 | 2024-2025 | Lifevest |
| Pfizer INC. | $66.14 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $37.84 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $35.52 | 2025 | Camzyos |
| Scpharmaceuticals INC. | $28.52 | 2025 | |
| Janssen Pharmaceuticals, INC | $18.42 | 2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $17.51 | 2024 | Assure Wcd |
| Davol INC. | $15.83 | 2024 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Komal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.